Sanara MedTech Inc. (SMTI) stock
SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30144% above fair value
$32.73−0.03 (-0.09%)
Close on Nov 17, 2026Market cap $300.72MP/E –Yield –
Sanara MedTech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Sanara MedTech's ebitda for the twelve months ending Jun 30, 2026 was $10.90M, up 4.1% year over year. For fiscal 2025 it was $11.25M, up 82.0% from the year before. The highest annual figure on record is $11.25M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.25M | +82.0% |
| FY2024 | Dec 31, 2024 | $6.18M | – |
| FY2023 | Dec 31, 2023 | -$540.13K | – |
| FY2022 | Dec 31, 2022 | -$10.15M | – |
| FY2021 | Dec 31, 2021 | -$6.78M | – |
| FY2020 | Dec 31, 2020 | -$4.74M | – |
| FY2019 | Dec 31, 2019 | -$2.62M | – |
| FY2018 | Dec 31, 2018 | -$417.97K | -307.9% |
| FY2017 | Dec 31, 2017 | $201.09K | – |
| FY2016 | Dec 31, 2016 | -$211.25K | – |
| FY2015 | Dec 31, 2015 | -$904.95K | – |
| FY2011 | Dec 31, 2011 | -$4.54M | – |
| FY2010 | Dec 31, 2010 | -$2.00M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.40M | -24.4% |
| Q1 FY2026 | Mar 31, 2026 | $3.23M | +65.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.72M | -55.6% |
| Q3 FY2025 | Sep 30, 2025 | $3.55M | +140.8% |
| Q2 FY2025 | Jun 30, 2025 | $3.18M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.95M | – |
| Q4 FY2024 | Dec 31, 2024 | $3.87M | +345.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.48M | +1521.0% |
| Q2 FY2024 | Jun 30, 2024 | -$1.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$426.29K | – |
| Q4 FY2023 | Dec 31, 2023 | $868.79K | – |
| Q3 FY2023 | Sep 30, 2023 | $91.02K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.06M | – |
| Q1 FY2023 | Mar 31, 2023 | -$437.45K | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.31M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.42M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.85M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.57M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.21M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.65M | – |
| Q2 FY2021 | Jun 30, 2021 | -$925.40K | – |
| Q1 FY2021 | Mar 31, 2021 | -$992.94K | – |
| Q4 FY2020 | Dec 31, 2020 | -$770.29K | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.23M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.01M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.74M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.42M | – |
| Q3 FY2019 | Sep 30, 2019 | -$751.46K | – |
| Q2 FY2019 | Jun 30, 2019 | -$300.59K | -669.2% |
| Q1 FY2019 | Mar 31, 2019 | -$152.81K | -275.7% |
| Q4 FY2018 | Dec 31, 2018 | -$447.06K | – |
| Q3 FY2018 | Sep 30, 2018 | -$110.68K | -976.7% |
| Q2 FY2018 | Jun 30, 2018 | $52.81K | -62.2% |
| Q1 FY2018 | Mar 31, 2018 | $86.96K | +11.0% |
| Q4 FY2017 | Dec 31, 2017 | -$29.44K | -110.1% |
| Q3 FY2017 | Sep 30, 2017 | $12.63K | -94.5% |
| Q2 FY2017 | Jun 30, 2017 | $139.54K | – |
| Q1 FY2017 | Mar 31, 2017 | $78.37K | – |
| Q4 FY2016 | Dec 31, 2016 | $291.93K | – |
| Q3 FY2016 | Sep 30, 2016 | $231.44K | – |
See a number that looks wrong?